Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
The concern about bioterrorism with smallpox has raised the possibility of widespread vaccination, but the greater prevalence of immunocompromised individuals today requires a safer vaccine, and the mechanisms of protection are not well understood. Here we show that, at sufficient doses, the protection provided by both modified vaccinia Ankara and NYVAC replication-deficient vaccinia viruses, safe in immunocompromised animals, was equivalent to that of the licensed Wyeth vaccine strain against a pathogenic vaccinia virus intranasal challenge of mice. A similar variety and pattern of immune responses were involved in protection induced by modified vaccinia Ankara and Wyeth viruses. For both, antibody was essential to protect against disease, whereas neither effector CD4 + nor CD8 + T cells were necessary or sufficient. However, in the absence of antibody, T cells were necessary and sufficient for survival and recovery. Also, T cells played a greater role in control of sublethal infection in unimmunized animals. These properties, shared with the existing smallpox vaccine, provide a basis for further evaluation of these replication-deficient vaccinia viruses as safer vaccines against smallpox or against complications from vaccinia virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B. J., et al. (1999) · Science · doi:10.1126/science.283.5403.857 · Cited by 2,187
(1988) · World Health Organization eBooks · Cited by 1,574
Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407
Inhibition of Viral Replication by Interferon-γ-Induced Nitric Oxide Synthase
Karupiah, G., Xie, Q.-W., Buller, R. M. L., Nathan, C., Duarte, C., & MacMicking, J. D. (1993) · Science · doi:10.1126/science.7690156 · Cited by 816
Chakrabarti, S., Brechling, K., & Moss, B. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.12.3403 · Cited by 777
Self-citationNonreplicating vaccinia vector efficiently expresses recombinant genes.
Sutter, G., & Moss, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10847 · Cited by 600
Self-citationComplications of Smallpox Vaccination, 1968: National Surveillance in the United States
Lane, J. M., Ruben, F. L., Neff, J. M., & Millar, J. D. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911272812201 · Cited by 545
Immunoglobulin E Production in the Absence of Interleukin-4-Secreting CD1-Dependent Cells
Smiley, S. T., Kaplan, M. H., & Grusby, M. J. (1997) · Science · doi:10.1126/science.275.5302.977 · Cited by 489
Strategies for designing and optimizing new generation vaccines
Berzofsky, J. A., Ahlers, J. D., & Belyakov, I. M. (2001) · Nature Reviews Immunology · doi:10.1038/35105075 · Cited by 334
Self-citationLin, C.-L., Chung, C.-S., Heine, H. G., & Chang, W. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3353-3365.2000 · Cited by 322
Nonparametric methods in factorial designs
Brunner, E., & Puri, M. L. (2001) · Statistical Papers · doi:10.1007/s003620000039 · Cited by 278
Successful T cell priming in B cell-deficient mice.
Epstein, M. M., Di Rosa, F., Jankovic, D., Sher, A., & Matzinger, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.4.915 · Cited by 277
Belyakov, I. M., Derby, M. A., Ahlers, J. D., Kelsall, B. L., Earl, P., Moss, B., Strober, W., & Berzofsky, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1709 · Cited by 258
Self-citationBasic and applied influenza research
Beare, A. S. (1982) · CRC Press eBooks · Cited by 254
Belyakov, I. M., Hel, Z., Kelsall, B., Kuznetsov, V. A., Ahlers, J. D., Nacsa, J., Watkins, D. I., Allen, T. M., Sette, A., Altman, J., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1320 · Cited by 232
Self-citationNeutralizing and Protective Antibodies Directed against Vaccinia Virus Envelope Antigens
Galmiche, M. C., Goenaga, J., Wittek, R., & Rindisbacher, L. (1999) · Virology · doi:10.1006/viro.1998.9516 · Cited by 218
Engelstad, M., Howard, S. T., & Smith, G. L. (1992) · Virology · doi:10.1016/0042-6822(92)90535-w · Cited by 214
Wolffe, E. J., Vijaya, S., & Moss, B. (1995) · Virology · doi:10.1006/viro.1995.1378 · Cited by 197
Self-citationIMMUNE RESPONSE TO CHEMICALLY MODIFIED FLAGELLIN
Parish, C. R., & Liew, F. Y. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.135.2.298 · Cited by 194
Dose-Related Effects of Smallpox Vaccine
Frey, S. E., Newman, F. K., Cruz, J., Shelton, W. B., Tennant, J. M., Polach, T., Rothman, A. L., Kennedy, J. S., Wolff, M., Belshe, R. B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013431 · Cited by 183
Belyakov, I. M., Moss, B., Strober, W., & Berzofsky, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4512 · Cited by 168
Self-citationKarupiah, G., Buller, R. M., Van Rooijen, N., Duarte, C. J., & Chen, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8301-8309.1996 · Cited by 167
Bioterrorism: A clear and present danger
Lane, H. C., Montagne, J. L., & Fauci, A. S. (2001) · Nature Medicine · doi:10.1038/nm1201-1271 · Cited by 166
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
Harris, N., Buller, R. M., & Karupiah, G. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.910-915.1995 · Cited by 163
Belyakov, I. M., Ahlers, J. D., Brandwein, B. Y., Earl, P., Kelsall, B. L., Moss, B., Strober, W., & Berzofsky, J. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci5102 · Cited by 160
Self-citationHomann, D., Tishon, A., Berger, D. P., Weigle, W. O., von Herrath, M. G., & Oldstone, M. B. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.9208-9216.1998 · Cited by 158
Topham, D. J., Tripp, R. A., Hamilton-Easton, A. M., Sarawar, S. R., & Doherty, P. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.7.2947 · Cited by 157
Drexler, I., Staib, C., Kastenmüller, W., Stevanović, S., Schmidt, B., Lemonnier, F. A., Rammensee, H., Busch, D. H., Bernhard, H., Erfle, V., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262668999 · Cited by 153
Rowland‐Jones, S., Tan, R., & McMichael, A. J. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60745-2 · Cited by 123
Elkins, K. L., Bosio, C. M., & Rhinehart-Jones, T. R. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.6002-6007.1999 · Cited by 113
The Use of Vaccinia Hyperimmune Gammaglobulin in the Prophylaxis of Smallpox
Kempe, C. H., Bowles, C., Meiklejohn, G., Berge, T. O., Saint-Vincent, L., Babu, B. V. S., Govindarajan, S., Ratnakannan, N. R., Downie, A. W., & Murthy, V. R. (2015) · Association Internationale des Soci�t�s de Microbiologie · doi:10.1159/000389848 · Cited by 113
Mozdzanowska, K., Maiese, K., & Gerhard, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2635 · Cited by 95
Berzofsky, J. A., Ahlers, J. D., Derby, M. A., Pendleton, C. D., Arichi, T., & Belyakov, I. M. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01336.x · Cited by 93
Self-citationTryniszewska, E. A., Nacsa, J., Lewis, M. G., Silvera, P. M., Montefiori, D. C., Venzon, D. J., Hel, Z., Parks, R. W., Moniuszko, M., Tartaglia, J., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5347 · Cited by 91
Self-citationEpstein, S. L., Stack, A., Misplon, J. A., Lo, C.-Y., Mostowski, H. S., Bennink, J. R., & Subbarao, K. (2000) · International Immunology · doi:10.1093/intimm/12.1.91 · Cited by 74
Cited by
McFadden, G. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1099 · Cited by 523
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
Earl, P. L., Americo, J. L., Wyatt, L. S., Eller, L. A., Whitbeck, J. C., Cohen, G. H., Eisenberg, R. J., Hartmann, C. J., Jackson, D. L., Kulesh, D. A., et al. (2004) · Nature · doi:10.1038/nature02331 · Cited by 455
Self-citationEdghill-Smith, Y., Golding, H., Manischewitz, J., King, L. R., Scott, D., Bray, M., Nalca, A., Hooper, J. W., Whitehouse, C. A., Schmitz, J. E., et al. (2005) · Nature Medicine · doi:10.1038/nm1261 · Cited by 452
Self-citationJump-starting the immune system: prime–boosting comes of age
Woodland, D. L. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.009 · Cited by 346
Smallpox DNA Vaccine Protects Nonhuman Primates against Lethal Monkeypox
Hooper, J. W., Thompson, E., Wilhelmsen, C., Zimmerman, M., Ichou, M. A., Steffen, S. E., Schmaljohn, C. S., Schmaljohn, A. L., & Jahrling, P. B. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4433-4443.2004 · Cited by 320
Metadata
- Authors
- Belyakov, I. M., Earl, P., Dzutsev, A., Kuznetsov, V. A., Lemon, M., Wyatt, L. S., Snyder, J. T., Ahlers, J. D., Franchini, G., Moss, B., & Berzofsky, J. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-07-17
- Volume
- 100
- Issue
- 16
- Pages
- 9458-9463
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2160885488
- Cited by
- 278
- References
- 35
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.